News
The Nevada Overdose Data to Action (OD2A) team has released November 2026 updates for public health partners, providers, and community organizations working on overdose prevention. New monthly DOSE reports track non-fatal overdose emergency department visits through October 2026 and show lower counts in most Nevada regions compared to prior years, offering regional insight to support local planning, outreach, and response. Partners can also join the monthly OD2A office hours on November 20 for one-on-one help with overdose data questions.
This blog examines the intersection of ADHD, prescription stimulant use, and recovery within the context of high-demand modern life. It addresses the broader culture of non-medical stimulant misuse for workplace productivity while highlighting the distinct realities of neurodivergent adults who rely on prescribed treatment for executive function support. The post explores the neurobiological link between undertreated ADHD and substance use, showing how substances are often used as a form of self-medication for nervous system regulation rather than recreation. Ultimately, it advocates for neuroaffirming recovery approaches, combining clinical care, environmental accommodations, practical task-anchoring strategies, and inclusive peer support to help neurodivergent adults thrive without sacrificing their health or recovery.
Each year, on October 23-31, individuals, schools, and communities across the United States show their commitment to a healthy, drug-free lifestyle by wearing or displaying the red ribbon. Red Ribbon Week raises awareness of drug use and the problems related to drugs faced by individuals, families, and communities. This annual health observance encourages parents, educators, business owners, and other community organizations to promote drug-free lifestyles.
Nevada Essentials for Childhood (NVEFC) has released new reports in its online data library, offering a closer look at what Nevada’s children and youth are experiencing. The reports share the latest findings on Positive Childhood Experiences (PCEs), Adverse Childhood Experiences (ACEs), and Nevada Syndromic Surveillance.
Kratom, a tropical botanical product that produces stimulant effects at low doses and opioid-like effects at higher doses, has become a central focus of public health discussions due to its potential for physical dependence and adverse health events. While Nevada initially pioneered a harm-reduction model through the 2019 Kratom Consumer Protection Act to regulate adult sales, product labeling, and purity, rising health concerns over high-potency extracts have led state regulators and the Nevada State Board of Pharmacy to evaluate classifying kratom as a Schedule I controlled substance.
The Nevada Overdose Data to Action (OD2A) team has released October updates, including new monthly surveillance reports and upcoming office hours for partners interested in overdose data.